Skip to content

Tailored Internet-administrated Treatment of Panic Symptoms - A Randomised Controlled Trial

Tailored Internet-administrated Treatment of Panic Symptoms - A Randomised Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01296321
Acronym
NOVA III
Enrollment
57
Registered
2011-02-15
Start date
2010-02-28
Completion date
2011-04-30
Last updated
2011-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Depression

Brief summary

The purpose of this study is to determine whether tailored internet-administrated CBT is a feasible approach in the treatment of panic symptoms and comorbid anxiety and depressive symptoms.

Interventions

This intervention contains 6-8 text-based self-help modules in which 4 modules are fixed (the first three and the last) and the rest are prescribed following the diagnostic telephone interview. These modules contain material on panic disorder, social phobia, stress management, assertiveness training, concentration, relaxation among other things.

BEHAVIORALWaitlist

Passive waitlist during 8-10 weeks.

Sponsors

Linkoeping University
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Be between the ages of 18-30 years old or 31-46 years old * Have reoccurring panic attacks

Exclusion criteria

* Suicide prone * Alcohol addiction * PTSD * OCD * Ongoing psychological treatment

Design outcomes

Primary

MeasureTime frameDescription
Panic Disorder Severity Scale (PDSS)Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in panic symptoms two weeks post treatment, at six months and at 12 months post treatment.

Secondary

MeasureTime frameDescription
Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in anxiety and depressive symptoms two weeks post treatment, at six months and at 12 months post treatment.
Beck Anxiety Inventory (BAI)Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.
Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S)Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in depressive symptoms two weeks post treatment, at six months and at 12 months post treatment.
Quality of Life Inventory (QOLI)Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatmentChange from baseline in quality of life statements two weeks post treatment, at six months and at 12 months post treatment.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026